Weight changes after hospitalization for worsening heart failure and subsequent re-hospitalization and mortality in the EVEREST trial

Aims Increases in body weight (BW) are important determinants for hospitalization in ambulatory patients with heart failure (HF), but have not yet been explored in patients hospitalized for worsening HF. We explore the relationship between change in BW after hospitalization for worsening HF and risk...

Full description

Saved in:
Bibliographic Details
Published inEuropean heart journal Vol. 30; no. 13; pp. 1666 - 1673
Main Authors Blair, John E.A., Khan, Sadiya, Konstam, Marvin A., Swedberg, Karl, Zannad, Faiez, Burnett, John C., Grinfeld, Liliana, Maggioni, Aldo P., Udelson, James E., Zimmer, Christopher A., Ouyang, John, Chen, Chien-Feng, Gheorghiade, Mihai
Format Journal Article
LanguageEnglish
Published England Oxford University Press 01.07.2009
Oxford Publishing Limited (England)
Subjects
Online AccessGet full text
ISSN0195-668X
1522-9645
1522-9645
DOI10.1093/eurheartj/ehp144

Cover

More Information
Summary:Aims Increases in body weight (BW) are important determinants for hospitalization in ambulatory patients with heart failure (HF), but have not yet been explored in patients hospitalized for worsening HF. We explore the relationship between change in BW after hospitalization for worsening HF and risk for repeat hospitalization and mortality in the EVEREST trial. Methods and results The EVEREST trial randomized 4133 patients hospitalized for worsening HF and low ejection fraction (≤40%) to tolvaptan, a vasopressin antagonist, or placebo. Following discharge, BW was assessed at 1, 4, and 8 weeks, and every 8 weeks thereafter. A time-dependent Cox proportional Hazard model explored the relationship between change in BW at 60, 120, and 180 days from discharge and the risks of HF hospitalization, cardiovascular (CV) hospitalization, and all-cause mortality. For subjects re-hospitalized for heart failure at 60, 120, and 180 days after discharge, mean BW increase prior to the event was 1.96, 2.07, and 1.97 kg, respectively, compared with 0.74, 0.90, and 1.04 kg in patients without re-hospitalization (P < 0.001 all groups). A similar pattern was observed with CV hospitalization. However, increases in BW were not predictive of all-cause mortality. Conclusion Increases in BW after hospitalization for worsening HF was predictive of repeat hospitalization events, but not mortality in the post-discharge period.
Bibliography:ark:/67375/HXZ-JJM92X41-5
istex:8A5708A2461775BD3FC5C78075B53F8DED6D151C
ArticleID:ehp144
Presented at the 2008 European Society of Cardiology Congress, and summarized by Dr Helmut Drexler in the highlight session ‘Heart failure and cardiomyopathies.’
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
ISSN:0195-668X
1522-9645
1522-9645
DOI:10.1093/eurheartj/ehp144